We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » WHO’s COVID-19 Countermeasure Program Focusing on Vaccines, Antibodies and Dexamethasone
WHO’s COVID-19 Countermeasure Program Focusing on Vaccines, Antibodies and Dexamethasone
The World Health Organization (WHO)’s ACT-Accelerator program is focusing on increasing global access to dexamethasone and monoclonal antibodies and has built up significant vaccine manufacturing capabilities, but it has zero plans for facilitating access to the only FDA-approved COVID-19 treatment, remdesivir.